wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35157329-019FE80B-D2B9-41BE-82B2-C77067D59F51
Q35157329-019FE80B-D2B9-41BE-82B2-C77067D59F51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35157329-019FE80B-D2B9-41BE-82B2-C77067D59F51
Postmenopausal overactive bladder
P2860
Q35157329-019FE80B-D2B9-41BE-82B2-C77067D59F51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35157329-019FE80B-D2B9-41BE-82B2-C77067D59F51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a94df75a93404f485d5c320c77c61311733ba3ca
P2860
A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.